Fermenta Biotech (BOM:506414) Inventories, Work In Process: ₹629 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:506414 Fermenta Biotech Ltd BOM:506414
65 GF Score
Price ₹499.30
GF Value ₹321.75
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Fermenta Biotech Inventories, Work In Process?

Fermenta Biotech BOM:506414 +7.25% 65 Inventories, Work In Process is ₹629 Mil as of Mar. 2026. GuruFocus rates BOM:506414 with a GF Score™ of 65/100 and a GF Value™ of ₹321.75 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Fermenta Biotech's work in process for the quarter that ended in Mar. 2026 was ₹629 Mil.

Fermenta Biotech Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Fermenta Biotech's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fermenta Biotech Inventories, Work In Process Chart

Fermenta Biotech Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Work In Process
Get a 7-Day Free Trial Premium Member Only Premium Member Only 606.55 341.68 335.88 403.46 629.43

Fermenta Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 403.46 0.00 0.00 0.00 629.43
BOM:506414
65GF Score
Fermenta Biotech Ltd BOM:506414
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fermenta Biotech Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of ₹629 Mil mean?
Fermenta Biotech (BOM:506414) has a Inventories, Work In Process of ₹629 Mil as of Mar. 2026. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Fermenta Biotech and its competitors.
Is Fermenta Biotech's Inventories, Work In Process too high?
Fermenta Biotech's current Inventories, Work In Process is ₹629 Mil. Overall, Fermenta Biotech has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fermenta Biotech's Inventories, Work In Process compare to ZTS?
Fermenta Biotech's Inventories, Work In Process of ₹629 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Drug Manufacturers company?
A good Inventories, Work In Process depends on the Drug Manufacturers industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Fermenta Biotech and its competitors. Fermenta Biotech's current Inventories, Work In Process is ₹629 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fermenta Biotech stock overvalued right now?
Based on GuruFocus' analysis, Fermenta Biotech (BOM:506414) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹321.75, compared to a current price of ₹499.30 — trading 55.2% above its estimated fair value. The current Inventories, Work In Process is ₹629 Mil. Fermenta Biotech's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Fermenta Biotech (BOM:506414), the current Inventories, Work In Process is ₹629 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fermenta Biotech (BOM:506414) Overvalued in 2026?

Based on GuruFocus' analysis, Fermenta Biotech stock appears to be overvalued. The current stock price of ₹499.30 is trading 55.2% above its estimated GF Value™ of ₹321.75. GuruFocus considers Fermenta Biotech to be Significantly Overvalued.

Key valuation signals for BOM:506414:

  • Inventories, Work In Process: ₹629 Mil
  • GF Value™: ₹321.75 vs. price of ₹499.30 (55.2% above fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the BOM:506414 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fermenta Biotech Business Description

Address Ghodbunder Road, A -1501, Thane One, DIL Complex, Majiwada, Thane (West), Thane, MH, IND, 400610
Fermenta Biotech Ltd is engaged in the business of manufacturing and marketing chemicals, bulk drugs, enzymes, pharmaceutical formulations, and environmental solution products and renting and selling properties. It is a manufacturer and supplier of Vitamin D and also supplies Penicillin G Amidase, CAL B Lipase, Polymer Supports, and enzyme technologies. The company operates in two segments namely Property and Bulk Drugs/Chemicals. The majority of the revenue comes from the Bulk Drug/Chemicals segment. Geographically, it caters to both domestic and international markets and generates maximum revenue from the Indian market.
65GF Score

Get the complete analysis for BOM:506414

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹499.30
Price
₹321.75
GF Value